Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shattuck Labs, Inc. (STTK)
USD6.40
+0.11 (+1.67%)
US NASDAQ Healthcare Biotechnology
Address
500 West 5th Street 78703
Austin, TX, US
Austin, TX, US
CEO
Taylor H. Schreiber
Website
shattucklabs.com
IPO
2020-10-09
CIK 1680367 ISIN US82024L1035
Description
Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission is to create innovative therapeutics designed to combat both cancer and autoimmune diseases. The company's leading experimental compound, SL-172154, is presently undergoing Phase 1 clinical assessment for the treatment of ovarian, fallopian tube, and peritoneal cancers. Furthermore, Shattuck Labs is advancing another product candidate, SL-279252, which is also in Phase 1 trials for patients afflicted with advanced solid tumors and lymphoma. Established in 2016, the company maintains its corporate headquarters in Austin, Texas.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD6.40
+0.11 (+1.67%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.09
Float Shares
45.24M
Free Float %
94.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.70% | -0.45% | -4.34% | +69.31% | +244.79% | +81.37% | +568.01% | +154.62% | -76.14% | -65.79% | -65.79% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
6.40
Low
11.00
+72.0%
Consensus
14.67
+129.4%
Median
15.00
+134.6%
High
18.00
+181.5%
DCF (Unlevered)
0.62
-90.3%
DCF (Levered)
0.47
-92.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
88% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
18.00
+181.5%
|
| Last Quarter | 1 |
18.00
+181.5%
|
| Last Year | 4 |
10.25
+60.3%
|
| All Time | 6 |
10.83
+69.3%
|
Quality scores
Altman Z-Score
26.12
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-82.5%
-
EPS growth Biotechnology: +29.7%+53.0% ★ Q1'26: +51.9% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-4,867.6%
-
EBIT margin Biotechnology: +0.0%-5,150.8%
-
ROIC Biotechnology: -16.1%-871.7% Q1'26: -834.3% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+37.1% Q1'26: +120.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.03× Q1'26: -0.03× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.93M
est: 10.00M (-0.6%)
|
30.02M
est: 2.26M (+1,226.4%)
|
652.0K
est: 247.3K (+163.6%)
|
1.66M
est: 4.12M (-59.8%)
|
5.72M
est: 6.51M (-12.1%)
|
1.00M
est: 1.17M (-14.3%)
|
1.60M
1.60M – 1.60M
+37.1% YoY
|
19.30M
19.30M – 19.30M
+1,106.3% YoY
|
2.50M
2.50M – 2.50M
-87.0% YoY
|
1.21M
1.21M – 1.21M
-51.5% YoY
|
1.27M
1.27M – 1.27M
+4.9% YoY
|
| EBITDA |
-36.31M
est: -10.00M (-263.3%)
|
-43.89M
est: -2.26M (-1,839.4%)
|
-100.26M
est: -247.3K (-40,434.8%)
|
-87.92M
est: -4.12M (-2,031.8%)
|
-76.74M
est: -6.51M (-1,079.2%)
|
-47.82M
est: -1.17M (-3,998.9%)
|
-1.60M
-1.60M – -1.60M
-37.1% YoY
|
-19.30M
-19.30M – -19.30M
-1,106.3% YoY
|
-2.50M
-2.50M – -2.50M
+87.0% YoY
|
-1.21M
-1.21M – -1.21M
+51.5% YoY
|
-1.27M
-1.27M – -1.27M
-4.9% YoY
|
| EBIT |
-36.93M
est: -10.00M (-269.5%)
|
-45.27M
est: -2.26M (-1,900.4%)
|
-103.33M
est: -247.3K (-41,677.3%)
|
-91.96M
est: -4.12M (-2,129.8%)
|
-80.57M
est: -6.51M (-1,138.0%)
|
-51.51M
est: -1.17M (-4,315.0%)
|
-1.60M
-1.60M – -1.60M
-37.1% YoY
|
-19.30M
-19.30M – -19.30M
-1,106.3% YoY
|
-2.50M
-2.50M – -2.50M
+87.0% YoY
|
-1.21M
-1.21M – -1.21M
+51.5% YoY
|
-1.27M
-1.27M – -1.27M
-4.9% YoY
|
| Net Income |
-36.60M
est: -96.14M (+61.9%)
|
-44.97M
est: -86.46M (+48.0%)
|
-101.95M
est: -92.12M (-10.7%)
|
-87.30M
est: -127.04M (+31.3%)
|
-75.41M
est: -100.62M (+25.1%)
|
-48.81M
est: -54.16M (+9.9%)
|
-41.86M
-55.58M – -28.14M
+22.7% YoY
|
-41.94M
-59.05M – -24.83M
-0.2% YoY
|
-50.04M
-75.97M – -24.11M
-19.3% YoY
|
-41.75M
-41.75M – -41.75M
+16.6% YoY
|
-62.63M
-62.63M – -62.63M
-50.0% YoY
|
| SGA |
9.38M
est: 97.74M (-90.4%)
|
18.72M
est: 22.13M (-15.4%)
|
21.08M
est: 2.42M (+771.8%)
|
19.30M
est: 53.76M (-64.1%)
|
19.08M
est: 84.83M (-77.5%)
|
17.24M
est: 15.21M (+13.3%)
|
20.86M
20.86M – 20.86M
+37.1% YoY
|
251.59M
251.59M – 251.59M
+1,106.3% YoY
|
32.59M
32.59M – 32.59M
-87.0% YoY
|
15.79M
15.79M – 15.79M
-51.5% YoY
|
16.57M
16.57M – 16.57M
+4.9% YoY
|
| EPS |
-0.88
est: -1.89 (+53.5%)
|
-1.07
est: -1.70 (+37.2%)
|
-2.41
est: -2.42 (+0.5%)
|
-2.05
est: -1.83 (-12.3%)
|
-1.49
est: -1.45 (-3.0%)
|
-0.70
est: -0.77 (+8.8%)
|
-0.51
-0.80 – -0.40
+34.1% YoY
|
-0.52
-0.85 – -0.36
-3.0% YoY
|
-0.59
-1.09 – -0.35
-12.5% YoY
|
-0.60
-0.60 – -0.60
-2.4% YoY
|
-0.90
-0.90 – -0.90
-50.0% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | HC Wainwright & Co. | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-47.28M
OE per share TTM
-0.61
Owner's Yield
-6.73%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
107.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
7
Total invested
17.32M
Insider transactions (90d)
0
Beneficial owners (>5%)
21
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Abigail P. Johnson | 5.93M | 14.20% | — | — | 5.93M | — | IN | Delaware | 2020-11-10 | ↗ |
| 2 | FMR LLC | 5.93M | 14.20% | 914.6K | — | 5.93M | — | HC | Delaware | 2020-11-10 | ↗ |
| 3 | Jeremy C. Green | 5.62M | 13.50% | — | 5.62M | — | 10.00 | HC, IN | — | 2020-10-15 | ↗ |
| 4 | Redmile Group, LLC | 5.62M | 13.50% | — | 5.62M | — | 10.00 | IA, OO | — | 2020-10-15 | ↗ |
| 5 | Josiah Hornblower | 3.41M | 8.20% | 3.41M | — | 3.41M | 11.00 | IN | — | 2020-10-23 | ↗ |
| 6 | Prosight Management, LP | 2.78M | 5.90% | — | 2.78M | — | 2.78M | IA | Delaware | 2024-01-02 | ↗ |
| 7 | Prosight Partners, LLC | 2.78M | 5.90% | — | 2.78M | — | 2.78M | OO | Delaware | 2024-01-02 | ↗ |
| 8 | W. Lawrence Hawkins | 2.78M | 5.90% | — | 2.78M | — | 2.78M | HC, IN | Delaware | 2024-01-02 | ↗ |
| 9 | Taylor Schreiber, M.D., Ph.D. | 2.71M | 6.50% | 2.71M | — | 2.71M | 11.00 | IN | — | 2020-10-23 | ↗ |
| 10 | (1) BlackRock, Inc. | 2.61M | 5.50% | 2.59M | — | 2.61M | — | HC | Delaware | 2024-11-08 | ↗ |
| 11 | Adage Capital Management, L.P. | 2.58M | 5.47% | — | 2.58M | — | — | IA, PN | Delaware | 2024-01-29 | ↗ |
| 12 | Adage Capital Partners GP, L.L.C. | 2.58M | 5.47% | — | 2.58M | — | — | OO | Delaware | 2024-01-29 | ↗ |
| 13 | Adage Capital Partners, L.P. | 2.58M | 5.47% | — | 2.58M | — | — | PN | Delaware | 2024-01-29 | ↗ |
| 14 | Phillip Gross | 2.58M | 5.47% | — | 2.58M | — | — | IN | Delaware | 2024-01-29 | ↗ |
| 15 | Robert Atchinson | 2.58M | 5.47% | — | 2.58M | — | — | IN | Delaware | 2024-01-29 | ↗ |
| 16 | Redmile Biopharma Investments II, L.P. | 2.18M | 5.20% | — | 2.18M | — | 10.00 | PN | — | 2020-10-15 | ↗ |
| 17 | Prosight Plus Fund, LP | 726.1K | 1.50% | — | 726.1K | — | 726.1K | PN | Delaware | 2024-01-02 | ↗ |
| 18 | Prosight Fund, LP | 244.6K | 0.50% | — | 244.6K | — | 244.6K | PN | Delaware | 2024-01-02 | ↗ |
| 19 | EcoR1 Capital Fund Qualified, L.P. | — | 11.00% | — | — | — | — | PN | Delaware | 2022-02-14 | ↗ |
| 20 | EcoR1 Capital, LLC | — | 11.00% | — | — | — | — | IA, OO | Delaware | 2022-02-14 | ↗ |
| 21 | Oleg Nodelman | — | 11.00% | — | — | — | — | HC, IN | United States | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
7
-56 vs prev Q
New positions
1
Closed positions
57
Increased
3
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 3.15M +3.1M (+100.0%) | 11.50B +11.5B (+100.0%) | 4.36% +4.364 pp | 6.74% +6.744 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 2 | EP WEALTH ADVISORS, LLC | 41.2K +41.2K (+100.0%) | 150.26M +150.3M (+100.0%) | 0.06% +0.057 pp | 0.00% +0.001 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 3 | ORBIMED ADVISORS LLC | 6.31M +— (+0.0%) | 23.02M +7.9M (+52.7%) | 8.74% -3.628 pp | 0.47% +0.117 pp | USD2.39 +52.7% | 2 qtrs — |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.31M +— (+0.0%) | 23.02M +7.9M (+52.7%) | 8.74% -3.628 pp | 0.03% +0.011 pp | USD4.13 -11.6% | 9 qtrs — |
| 5 | REDMILE GROUP, LLC | 5.54M +— (+0.0%) | 20.22M +7.0M (+52.7%) | 7.67% -3.187 pp | 1.49% +0.201 pp | USD52.41 -93.0% | 21 qtrs — |
| 6 | PROSIGHT MANAGEMENT, LP | 2.38M -3.1M (-56.3%) | 8.69M -4.3M (-33.3%) | 3.30% -7.389 pp | 1.80% -1.242 pp | USD4.72 -22.7% | 18 qtrs — |
| 7 | VANGUARD GROUP INC | 2.38M +249.3K (+11.7%) | 8.68M +3.6M (+70.6%) | 3.29% -0.879 pp | 0.00% +0.000 pp | USD19.78 -81.5% | 21 qtrs — |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.93M +1.9M (+100.0%) | 7.03M +7.0M (+100.0%) | 2.67% +2.668 pp | 0.00% +0.001 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 9 | CLARK ESTATES INC/NY | 1.48M +— (+0.0%) | 5.39M +1.9M (+52.7%) | 2.04% -0.849 pp | 1.31% +0.501 pp | USD24.08 -84.8% | 21 qtrs — |
| 10 | 683 CAPITAL MANAGEMENT, LLC | 1.39M -142.2K (-9.3%) | 5.07M +1.4M (+38.5%) | 1.93% -1.079 pp | 0.22% +0.029 pp | USD1.53 +138.6% | 5 qtrs — |
| 11 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.35M +1.4M (+100.0%) | 4.95M +4.9M (+100.0%) | 1.88% +1.877 pp | 0.00% +0.003 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 12 | PINNACLE ASSOCIATES LTD | 1.35M -38.1K (-2.7%) | 4.93M +1.6M (+48.5%) | 1.87% -0.852 pp | 0.06% +0.019 pp | USD2.06 +77.2% | 11 qtrs — |
| 13 | BANK OF AMERICA CORP /DE/ | 1.11M -25.3K (-2.2%) | 4.04M +1.3M (+49.3%) | 1.53% -0.686 pp | 0.00% +0.000 pp | USD2.39 +52.7% | 21 qtrs — |
| 14 | POINT72 ASSET MANAGEMENT, L.P. | 1.07M +1.1M (+100.0%) | 3.90M +3.9M (+100.0%) | 1.48% +1.480 pp | 0.00% +0.004 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 618.3K +150.3K (+32.1%) | 2.26M +1.1M (+101.7%) | 0.86% -0.061 pp | 0.00% +0.000 pp | USD11.28 -67.6% | 21 qtrs — |
| 16 | ABRDN PLC | 531.2K +436.7K (+462.1%) | 1.94M +1.7M (+758.4%) | 0.74% +0.551 pp | 0.00% +0.003 pp | USD3.43 +6.4% | 2 qtrs — |
| 17 | MARSHALL WACE, LLP | 489.9K -166.7K (-25.4%) | 1.79M +218.8K (+13.9%) | 0.68% -0.609 pp | 0.00% +0.000 pp | USD2.39 +52.7% | 2 qtrs — |
| 18 | MILLENNIUM MANAGEMENT LLC | 477.4K -213.5K (-30.9%) | 1.74M +91.3K (+5.5%) | 0.66% -0.693 pp | 0.00% +0.000 pp | USD1.92 +90.1% | 20 qtrs — |
| 19 | TWO SIGMA INVESTMENTS, LP | 437.7K +29.1K (+7.1%) | 1.60M +621.2K (+63.6%) | 0.61% -0.195 pp | 0.00% +0.001 pp | USD3.22 +13.4% | 8 qtrs — |
| 20 | BLACKROCK, INC. | 418.5K +7.2K (+1.8%) | 1.53M +544.6K (+55.4%) | 0.58% -0.227 pp | 0.00% +0.000 pp | USD3.47 +5.2% | 6 qtrs — |
| 21 | FMR LLC | 392.6K +389.2K (+11,560.2%) | 1.43M +1.4M (+17,707.8%) | 0.54% +0.537 pp | 0.00% +0.000 pp | USD3.87 -5.7% | 21 qtrs — |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 340.7K +123.8K (+57.1%) | 1.24M +725.2K (+139.9%) | 0.47% +0.047 pp | 0.00% +0.001 pp | USD3.13 +16.6% | 17 qtrs — |
| 23 | TD ASSET MANAGEMENT INC | 251.1K +251.1K (+100.0%) | 916.3K +916.3K (+100.0%) | 0.35% +0.348 pp | 0.00% +0.001 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 24 | STATE STREET CORP | 215.4K +38.7K (+21.9%) | 786.3K +363.9K (+86.2%) | 0.30% -0.048 pp | 0.00% +0.000 pp | USD6.60 -44.7% | 21 qtrs — |
| 25 | SPHERA FUNDS MANAGEMENT LTD. | 195.2K +195.2K (+100.0%) | 712.5K +712.5K (+100.0%) | 0.27% +0.270 pp | 0.14% +0.138 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 26 | TWO SIGMA ADVISERS, LP | 170.6K +57.9K (+51.4%) | 622.7K +353.4K (+131.2%) | 0.24% +0.015 pp | 0.00% +0.001 pp | USD2.97 +22.9% | 8 qtrs — |
| 27 | PATHSTONE HOLDINGS, LLC | 157.1K +— (+0.0%) | 573.4K +197.9K (+52.7%) | 0.22% -0.090 pp | 0.00% +0.001 pp | USD3.41 +7.0% | 9 qtrs — |
| 28 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 148.4K +80.3K (+117.9%) | 541.8K +379.0K (+232.8%) | 0.21% +0.072 pp | 0.00% +0.000 pp | USD2.65 +37.7% | 9 qtrs — |
| 29 | NORTHERN TRUST CORP | 145.4K +54.2K (+59.4%) | 530.9K +312.7K (+143.4%) | 0.20% +0.023 pp | 0.00% +0.000 pp | USD7.22 -49.4% | 21 qtrs — |
| 30 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 135.1K +135.1K (+100.0%) | 486.2K +486.2K (+100.0%) | 0.19% +0.187 pp | 0.00% +0.000 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 31 | GOLDMAN SACHS GROUP INC | 128.2K +111.4K (+662.9%) | 467.8K +427.7K (+1,065.1%) | 0.18% +0.145 pp | 0.00% +0.000 pp | USD3.42 +6.7% | 9 qtrs — |
| 32 | BANK OF NEW YORK MELLON CORP | 110.4K +— (+0.0%) | 402.9K +139.1K (+52.7%) | 0.15% -0.064 pp | 0.00% +0.000 pp | USD6.60 -44.7% | 21 qtrs — |
| 33 | LBJ FAMILY WEALTH ADVISORS, LTD. | 82.2K +— (+0.0%) | 300.0K +104.0K (+53.1%) | 0.11% -0.047 pp | 0.17% +0.058 pp | USD2.39 +52.7% | 7 qtrs — |
| 34 | ACADIAN ASSET MANAGEMENT LLC | 79.4K -249.9K (-75.9%) | 289.0K -496.0K (-63.2%) | 0.11% -0.536 pp | 0.00% -0.001 pp | USD1.41 +158.9% | 7 qtrs — |
| 35 | CITADEL ADVISORS LLC | 68.8K +68.8K (+100.0%) | 251.3K +251.3K (+100.0%) | 0.10% +0.095 pp | 0.00% +0.000 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 36 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 65.7K +65.7K (+100.0%) | 239.9K +239.9K (+100.0%) | 0.09% +0.091 pp | 0.00% +0.001 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 37 | SQUAREPOINT OPS LLC | 64.8K +45.5K (+236.4%) | 236.5K +190.4K (+413.7%) | 0.09% +0.052 pp | 0.00% +0.000 pp | USD3.28 +11.3% | 2 qtrs — |
| 38 | JANE STREET GROUP, LLC | 54.0K -45.0K (-45.4%) | 197.3K -39.5K (-16.7%) | 0.07% -0.119 pp | 0.00% +0.000 pp | USD1.10 +231.8% | 9 qtrs — |
| 39 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 42.3K +— (+0.0%) | 154.4K +53.3K (+52.7%) | 0.06% -0.024 pp | 0.00% +0.001 pp | USD1.84 +98.4% | 15 qtrs — |
| 40 | PIPER SANDLER & CO. | 39.5K +— (+0.0%) | 144.1K +49.7K (+52.7%) | 0.05% -0.023 pp | 0.10% +0.034 pp | USD40.32 -90.9% | 21 qtrs — |
| 41 | QUBE RESEARCH & TECHNOLOGIES LTD | 38.8K +22.8K (+143.0%) | 141.5K +103.3K (+271.1%) | 0.05% +0.022 pp | 0.00% +0.000 pp | USD2.47 +47.8% | 15 qtrs — |
| 42 | INVESCO LTD. | 28.2K +28.2K (+100.0%) | 103.0K +103.0K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.000 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 43 | OMERS ADMINISTRATION CORP | 26.5K +26.5K (+100.0%) | 96.7K +96.7K (+100.0%) | 0.04% +0.037 pp | 0.00% +0.001 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 44 | RITHOLTZ WEALTH MANAGEMENT | 26.0K +— (+0.0%) | 94.9K +32.8K (+52.7%) | 0.04% -0.015 pp | 0.00% +0.001 pp | USD19.87 -81.6% | 19 qtrs — |
| 45 | XTX TOPCO LTD | 24.9K -1.4K (-5.2%) | 90.8K +28.1K (+44.8%) | 0.03% -0.017 pp | 0.00% -0.001 pp | USD2.39 +52.7% | 2 qtrs — |
| 46 | CITIGROUP INC | 24.8K +9.7K (+64.4%) | 90.6K +54.5K (+151.0%) | 0.03% +0.005 pp | 0.00% +0.000 pp | USD3.56 +2.5% | 9 qtrs — |
| 47 | DIMENSIONAL FUND ADVISORS LP | 23.2K +23.2K (+100.0%) | 84.7K +84.7K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.000 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 48 | MALLINI COMPLETE FINANCIAL PLANNING LLC | 22.6K +22.6K (+100.0%) | 82.6K +82.6K (+100.0%) | 0.03% +0.031 pp | 0.07% +0.066 pp | USD3.65 +0.0% | 4 qtrs — |
| 49 | CHOREO, LLC | 27.3K +— (+0.0%) | 76.5K +22.9K (+42.8%) | 0.04% -0.016 pp | 0.00% +0.000 pp | USD1.08 +238.0% | 5 qtrs — |
| 50 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 20.9K +— (+0.0%) | 76.2K +26.3K (+52.7%) | 0.03% -0.012 pp | 0.00% +0.000 pp | USD9.40 -61.2% | 21 qtrs — |
| 51 | MORGAN STANLEY | 18.1K +1.5K (+8.8%) | 66.1K +26.3K (+66.1%) | 0.03% -0.008 pp | 0.00% +0.000 pp | USD5.42 -32.7% | 21 qtrs — |
| 52 | PRUDENTIAL FINANCIAL INC | 17.7K +— (+0.0%) | 64.6K +22.3K (+52.7%) | 0.02% -0.010 pp | 0.00% +0.000 pp | USD2.39 +52.7% | 4 qtrs — |
| 53 | AMERICAN CENTURY COMPANIES INC | 17.3K +17.3K (+100.0%) | 63.1K +63.1K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.000 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 54 | KEEL POINT, LLC | 14.3K -31.9K (-69.1%) | 52.1K -58.3K (-52.8%) | 0.02% -0.071 pp | 0.00% -0.004 pp | USD2.39 +52.7% | 2 qtrs — |
| 55 | ENGINEERS GATE MANAGER LP | 13.7K +— (+0.0%) | 49.9K +17.2K (+52.7%) | 0.02% -0.008 pp | 0.00% +0.000 pp | USD6.34 -42.4% | 8 qtrs — |
| 56 | UBS GROUP AG | 13.2K +11.8K (+821.4%) | 48.2K +44.8K (+1,307.2%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD3.47 +5.2% | 21 qtrs — |
| 57 | CREATIVE PLANNING | 12.3K +— (+0.0%) | 45.0K +15.5K (+52.7%) | 0.02% -0.007 pp | 0.00% +0.000 pp | USD2.39 +52.7% | 2 qtrs — |
| 58 | AMERIPRISE FINANCIAL INC | 11.5K +11.5K (+100.0%) | 42.0K +42.0K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 59 | STONERIDGE INVESTMENT PARTNERS LLC | 10.5K +10.5K (+100.0%) | 38.0K +38.0K (+100.0%) | 0.01% +0.015 pp | 0.03% +0.026 pp | USD3.65 +0.0% | 1 qtrs NEW |
| 60 | BNP PARIBAS ARBITRAGE, SNC | 540.00 -418.0 (-43.6%) | 2.0K -319.0 (-13.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.15 +217.4% | 5 qtrs — |
| 61 | JPMORGAN CHASE & CO | 343.00 +40.0 (+13.2%) | 1.3K +528.0 (+72.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.00 +82.5% | 21 qtrs — |
| 62 | SBI SECURITIES CO., LTD. | 92.00 +— (+0.0%) | 336.00 +116.0 (+52.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.20 +204.2% | 5 qtrs — |
| 63 | OPTIVER HOLDING B.V. | 66.00 +— (+0.0%) | 241.00 +83.0 (+52.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.38 +53.4% | 2 qtrs — |
| 64 | BARCLAYS PLC | — -54.3K (-100.0%) | — -189.5K (-100.0%) | 0.00% -0.107 pp | 0.00% +0.000 pp | USD— | 16 qtrs SOLD |
| 65 | ROYAL BANK OF CANADA | — -14.5K (-100.0%) | — -34.0K (-100.0%) | 0.00% -0.029 pp | 0.00% +0.000 pp | USD— | 11 qtrs SOLD |
| 66 | VIRTU FINANCIAL LLC | — -16.1K (-100.0%) | — -38.0K (-100.0%) | 0.00% -0.032 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 67 | TURTLE CREEK WEALTH ADVISORS, LLC | — -12.2K (-100.0%) | — -29.2K (-100.0%) | 0.00% -0.024 pp | 0.00% -0.003 pp | USD— | 2 qtrs SOLD |
| 68 | SRS CAPITAL ADVISORS, INC. | — -14.0 (-100.0%) | — -33.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 69 | ASSUREDPARTNERS INVESTMENT ADVISORS, LLC | — -10.0K (-100.0%) | — -23.9K (-100.0%) | 0.00% -0.020 pp | 0.00% -0.005 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 44 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.09% | 1.37M | 0.60% |
| 2 | Texas Capital Texas Equity Index ETF TXS | 0.07% | 25.1K | 0.49% |
| 3 | T. Rowe Price Innovation Leaders ETF TNXT | 0.07% | 12.6K | 0.49% |
| 4 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.05% | 524.8K | 0.20% |
| 5 | iShares Russell 2000 Growth ETF IWO | 0.02% | 3.34M | 0.24% |
| 6 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 381.5K | 0.30% |
| 7 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.01% | 726.4K | 0.30% |
| 8 | Global X - Russell 2000 ETF RSSL | 0.01% | 189.6K | 0.08% |
| 9 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.01% | 41.2K | 0.25% |
| 10 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 7.1K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.75
Neutral
Ratio by volume
3.00
Bullish
Buys
6
Sells
8
Shares acquired
3.63M
Shares disposed
32.0K
Cash buys
—
Cash sales
—
Net activity
+3,602,374
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-25 | Stout Stephen | Officer | F-InKind | D | Common Stock | 593 | 4.15 | 2.5K | 81,529 | D | ↗ |
| 2026-01-25 | Pandite Arundathy N. | Officer | F-InKind | D | Common Stock | 3,195 | 4.15 | 13.3K | 196,219 | D | ↗ |
| 2026-01-25 | Neill Andrew R | Officer | F-InKind | D | Common Stock | 2,589 | 4.15 | 10.7K | 228,224 | D | ↗ |
| 2026-01-25 | DeYoung Casi | Officer | F-InKind | D | Common Stock | 2,286 | 4.15 | 9.5K | 73,480 | D | ↗ |
| 2026-01-10 | Stout Stephen | Officer | A-Award | A | Stock Option (Right to Buy) | 351,400 | 4.75 | 1.67M | 351,400 | D | ↗ |
| 2026-01-10 | Shukla Abhinav A. | Officer | A-Award | A | Common Stock | 315,500 | 4.75 | 1.50M | 315,500 | D | ↗ |
| 2026-01-10 | Schreiber Taylor | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,548,300 | 4.75 | 7.35M | 1,548,300 | D | ↗ |
| 2026-01-10 | Pandite Arundathy N. | Officer | A-Award | A | Common Stock | 487,800 | 4.75 | 2.32M | 487,800 | D | ↗ |
| 2026-01-10 | Neill Andrew R | Officer | A-Award | A | Stock Option (Right to Buy) | 549,800 | 4.75 | 2.61M | 549,800 | D | ↗ |
| 2026-01-10 | DeYoung Casi | Officer | A-Award | A | Common Stock | 381,600 | 4.75 | 1.81M | 381,600 | D | ↗ |
| 2025-08-28 | Baker Daniel G. | Director | A-Award | A | Stock Option (Right to Buy) | 66,300 | 0.99 | 65.6K | 66,300 | D | ↗ |
| 2025-08-28 | Ashiya Mona | Director | A-Award | A | Stock Option (Right to Buy) | 66,300 | 0.99 | 65.6K | 66,300 | D | ↗ |
| 2025-08-25 | Stout Stephen | Officer | A-Award | A | Warrants (Right to Buy) | 12,805 | 1.08 | 13.9K | 12,805 | D | ↗ |
| 2025-08-25 | Shukla Abhinav A. | Officer | A-Award | A | Warrants (Right to Buy) | 5,122 | 1.08 | 5.6K | 5,122 | D | ↗ |
| 2025-08-25 | Schreiber Taylor | Director / Officer | A-Award | A | Warrants (Right to Buy) | 25,610 | 1.08 | 27.8K | 25,610 | D | ↗ |
| 2025-08-25 | SIEGALL CLAY B | Director | A-Award | A | Warrants (Right to Buy) | 128,054 | 1.08 | 138.9K | 128,054 | D | ↗ |
| 2025-08-25 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Pre-Funded Warrants to Purchase Common Stock | 4,097,730 | 0.00 | 409.77 | 7,198,553 | I | ↗ |
| 2025-08-25 | ORBIMED ADVISORS LLC | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-08-25 | Neill Andrew R | Officer | A-Award | A | Warrants (Right to Buy) | 64,027 | 1.08 | 69.4K | 64,027 | D | ↗ |
| 2025-08-25 | Baker Daniel G. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-08-25 | Ashiya Mona | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-07-14 | Sasser Amy Kate | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | SIEGALL CLAY B | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | I | ↗ |
| 2025-07-14 | Lee Michael Stewart | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | Golumbeski George | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | Gibson Neil W | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | Brownstein Carrie | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | Brous Tyler | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-07-14 | Boudreau Helen M | Director | A-Award | A | Stock Option (Right to Buy) | 33,150 | 0.82 | 27.2K | 33,150 | D | ↗ |
| 2025-01-28 | Stout Stephen | Officer | A-Award | A | Stock Option (Right to Buy) | 177,000 | 1.18 | 208.9K | 177,000 | D | ↗ |
| 2025-01-28 | Shukla Abhinav A. | Officer | A-Award | A | Common Stock | 165,200 | 1.18 | 194.9K | 165,200 | D | ↗ |
| 2025-01-28 | Schreiber Taylor | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 684,600 | 1.18 | 807.8K | 684,600 | D | ↗ |
| 2025-01-28 | Pandite Arundathy N. | Officer | A-Award | A | Common Stock | 206,200 | 1.18 | 243.3K | 206,200 | D | ↗ |
| 2025-01-28 | Neill Andrew R | Officer | A-Award | A | Stock Option (Right to Buy) | 214,000 | 1.18 | 252.5K | 214,000 | D | ↗ |
| 2025-01-28 | DeYoung Casi | Officer | A-Award | A | Common Stock | 194,300 | 1.18 | 229.3K | 194,300 | D | ↗ |
| 2025-01-25 | Shukla Abhinav A. | Officer | F-InKind | D | Common Stock | 2,261 | 1.16 | 2.6K | 73,536 | D | ↗ |
| 2025-01-25 | Pandite Arundathy N. | Officer | F-InKind | D | Common Stock | 3,211 | 1.16 | 3.7K | 206,265 | D | ↗ |
| 2025-01-25 | DeYoung Casi | Officer | F-InKind | D | Common Stock | 2,297 | 1.16 | 2.7K | 81,465 | D | ↗ |
| 2025-01-10 | Shukla Abhinav A. | Officer | F-InKind | D | Common Stock | 4,830 | 1.19 | 5.7K | 74,597 | D | ↗ |
| 2025-01-10 | Pandite Arundathy N. | Officer | F-InKind | D | Common Stock | 6,884 | 1.19 | 8.2K | 209,476 | D | ↗ |
| 2025-01-10 | DeYoung Casi | Officer | F-InKind | D | Common Stock | 5,727 | 1.19 | 6.8K | 83,762 | D | ↗ |
| 2024-12-04 | Redmile Group, LLC | Director / 10% Owner | J-Other | D | Common Stock, par value $0.0001 per share | 1,026,888 | 1.25 | 1.28M | 4,512,836 | I | ↗ |
| 2024-10-07 | Schreiber Taylor | Director / Officer | P-Purchase | A | Common Stock | 36,500 | 1.21 | 44.2K | 71,002 | D | ↗ |
| 2024-06-28 | Brous Tyler | Director | P-Purchase | A | Common Stock | 3,000 | 3.90 | 11.7K | 238,088 | — | ↗ |
| 2024-06-27 | Brous Tyler | Director | P-Purchase | A | Common Stock | 5,416 | 3.89 | 21.1K | 235,088 | — | ↗ |
| 2024-06-26 | Schreiber Taylor | Director / Officer | P-Purchase | A | Common Stock | 14,400 | 3.47 | 50.0K | 34,502 | — | ↗ |
| 2024-06-21 | Sasser Amy Kate | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | SIEGALL CLAY B | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Lee Michael Stewart | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Golumbeski George | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Gibson Neil W | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Brownstein Carrie | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Brous Tyler | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-21 | Boudreau Helen M | Director | A-Award | A | Stock Option (Right to Buy) | 27,700 | 4.37 | 121.0K | 27,700 | — | ↗ |
| 2024-06-04 | Schreiber Taylor | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,050 | 3.57 | 10.9K | 162,000 | — | ↗ |
| 2024-05-10 | Stout Stephen | Officer | F-InKind | D | Common Stock | 967 | 10.42 | 10.1K | 73,470 | — | ↗ |
| 2024-03-28 | Redmile Group, LLC | Director / 10% Owner | J-Other | D | Common Stock | 4,425 | 0.00 | — | 5,615,489 | — | ↗ |
| 2024-03-06 | Stout Stephen | Officer | M-Exempt | D | Stock Option (Right to Buy) | 4,650 | 3.51 | 16.3K | 9,300 | — | ↗ |
| 2024-03-06 | Sasser Amy Kate | Director | A-Award | A | Stock Option (Right to Buy) | 33,409 | 9.47 | 316.4K | 33,409 | — | ↗ |
| 2024-03-06 | SIEGALL CLAY B | Director | A-Award | A | Stock Option (Right to Buy) | 33,409 | 9.47 | 316.4K | 33,409 | — | ↗ |
| 2024-03-01 | Sasser Amy Kate | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-03-01 | SIEGALL CLAY B | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-30 | Stout Stephen | Officer | F-InKind | D | Common Stock | 593 | 9.99 | 5.9K | 79,332 | — | ↗ |
| 2024-01-30 | Shukla Abhinav A. | Officer | F-InKind | D | Common Stock | 2,290 | 9.99 | 22.9K | 79,427 | — | ↗ |
| 2024-01-30 | Pandite Arundathy N. | Officer | F-InKind | D | Common Stock | 2,920 | 9.99 | 29.2K | 216,360 | — | ↗ |
| 2024-01-30 | DeYoung Casi | Officer | F-InKind | D | Common Stock | 2,008 | 9.99 | 20.1K | 89,489 | — | ↗ |
| 2024-01-12 | Schreiber Taylor | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 330,100 | 9.41 | 3.11M | 330,100 | — | ↗ |
| 2024-01-10 | Stout Stephen | Officer | A-Award | A | Common Stock | 49,050 | 0.00 | — | 79,925 | — | ↗ |
| 2024-01-10 | Shukla Abhinav A. | Officer | A-Award | A | Stock Option (Right to Buy) | 66,850 | 10.09 | 674.5K | 66,850 | — | ↗ |
| 2024-01-10 | Pandite Arundathy N. | Officer | A-Award | A | Stock Option (Right to Buy) | 92,950 | 10.09 | 937.9K | 92,950 | — | ↗ |
| 2024-01-10 | Neill Andrew R | Officer | A-Award | A | Common Stock | 56,500 | 0.00 | — | 200,916 | — | ↗ |
| 2024-01-10 | DeYoung Casi | Officer | F-InKind | D | Common Stock | 1,583 | 10.09 | 16.0K | 91,497 | — | ↗ |
| 2023-12-21 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Pre-Funded Warrant to Purchase Common Stock | 3,100,823 | 0.00 | 310.08 | 3,100,823 | — | ↗ |
| 2023-05-26 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-26 | Lee Michael Stewart | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-26 | Golumbeski George | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-26 | Gibson Neil W | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-26 | Brownstein Carrie | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-26 | Brous Tyler | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-26 | Boudreau Helen M | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 2.72 | 109.5K | 40,258 | — | ↗ |
| 2023-05-10 | Stout Stephen | Officer | A-Award | A | Stock Option (Right to Buy) | 31,800 | 2.79 | 88.7K | 31,800 | — | ↗ |
| 2023-03-23 | Stout Stephen | Officer | — | D | Common Stock | 0 | 0.00 | — | 14,975 | — | ↗ |
| 2023-01-25 | Thomson Erin Ator | Officer | A-Award | A | Common Stock | 24,125 | 0.00 | — | 103,209 | — | ↗ |
| 2023-01-25 | Shukla Abhinav A. | Officer | A-Award | A | Common Stock | 26,100 | 0.00 | — | 47,092 | — | ↗ |
| 2023-01-25 | Schreiber Taylor | Officer | A-Award | D | Stock Option (Right to Buy) | 165,050 | 0.00 | — | 165,050 | — | ↗ |
| 2023-01-25 | Pandite Arundathy N. | Officer | A-Award | A | Stock Option (Right to Buy) | 69,750 | 0.00 | — | 69,750 | — | ↗ |
| 2023-01-25 | Neill Andrew R | Officer | A-Award | A | Stock Option (Right to Buy) | 69,850 | 0.00 | — | 69,850 | — | ↗ |
| 2023-01-25 | DeYoung Casi | Officer | A-Award | A | Common Stock | 27,100 | 0.00 | — | 46,880 | — | ↗ |
| 2023-01-10 | Shukla Abhinav A. | Officer | F-InKind | D | Common Stock | 1,933 | 3.03 | 5.9K | 20,992 | — | ↗ |
| 2023-01-10 | Pandite Arundathy N. | Officer | F-InKind | D | Common Stock | 2,987 | 3.03 | 9.1K | 137,917 | — | ↗ |
| 2023-01-10 | DeYoung Casi | Officer | F-InKind | D | Common Stock | 1,583 | 3.03 | 4.8K | 19,780 | — | ↗ |
| 2022-06-08 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 40,258 | 4.32 | 173.9K | 40,258 | — | ↗ |
| 2022-06-08 | Lee Michael Stewart | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2022-06-08 | Green Jeremy | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2022-06-08 | Golumbeski George | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2022-06-08 | Gibson Neil W | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2022-06-08 | Brownstein Carrie | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2022-06-08 | Brous Tyler | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 0.00 | — | 40,258 | — | ↗ |
| 2022-06-08 | Boudreau Helen M | Director | A-Award | A | Stock Option (Right to Buy) | 40,258 | 4.32 | 173.9K | 40,258 | — | ↗ |
| 2022-04-26 | Golumbeski George | Director | P-Purchase | A | Common Stock | 28,330 | 3.63 | 102.8K | 54,613 | — | ↗ |
| 2022-04-21 | Golumbeski George | Director | P-Purchase | A | Common Stock | 26,049 | 3.69 | 96.1K | 26,049 | — | ↗ |
| 2022-04-07 | Shukla Abhinav A. | Officer | — | D | Common Stock | 0 | 0.00 | — | 22,325 | — | ↗ |
| 2022-01-28 | Schreiber Taylor | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,926 | 4.67 | 18.3K | 176,597 | — | ↗ |
| 2022-01-19 | Brous Tyler | Director | P-Purchase | A | Common Stock | 3,000 | 6.87 | 20.6K | 229,672 | — | ↗ |
| 2022-01-18 | Brous Tyler | Director | P-Purchase | A | Common Stock | 2,500 | 7.01 | 17.5K | 226,672 | — | ↗ |
| 2022-01-14 | Brous Tyler | Director | P-Purchase | A | Common Stock | 2,500 | 7.16 | 17.9K | 224,172 | — | ↗ |
| 2022-01-12 | Thomson Erin Ator | Officer | M-Exempt | D | Stock Option (Right to Buy) | 10,000 | 2.95 | 29.5K | 53,705 | — | ↗ |
| 2022-01-10 | Thomson Erin Ator | Officer | A-Award | A | Stock Option (Right to Buy) | 45,650 | 7.43 | 339.2K | 45,650 | — | ↗ |
| 2022-01-10 | Schreiber Taylor | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 178,150 | 7.43 | 1.32M | 178,150 | — | ↗ |
| 2022-01-10 | Pandite Arundathy N. | Officer | A-Award | A | Stock Option (Right to Buy) | 69,475 | 7.43 | 516.2K | 69,475 | — | ↗ |
| 2022-01-10 | Neill Andrew R | Officer | A-Award | A | Stock Option (Right to Buy) | 66,650 | 7.43 | 495.2K | 66,650 | — | ↗ |
| 2022-01-10 | DeYoung Casi | Officer | A-Award | A | Common Stock | 21,363 | 0.00 | — | 21,363 | — | ↗ |
| 2021-11-12 | Brownstein Carrie | Director | A-Award | A | Stock Option (Right to Buy) | 10,467 | 19.27 | 201.7K | 10,467 | — | ↗ |
| 2021-11-11 | Neill Andrew R | Officer | M-Exempt | A | Common Stock | 20,000 | 2.95 | 59.0K | 76,166 | — | ↗ |
| 2021-11-10 | Schreiber Taylor | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,926 | 4.67 | 18.3K | 180,523 | — | ↗ |
| 2021-10-22 | Brownstein Carrie | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-10-19 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 33,000 | 19.50 | 643.5K | 46,259 | — | ↗ |
| 2021-08-10 | Schreiber Taylor | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,926 | 4.67 | 18.3K | 184,449 | — | ↗ |
| 2021-08-10 | Pandite Arundathy N. | Officer | M-Exempt | A | Common Stock | 4,259 | 0.01 | 42.59 | 106,166 | — | ↗ |
| 2021-08-10 | Neill Andrew R | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,203 | 0.01 | 22.03 | 0 | — | ↗ |
| 2021-07-15 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 2,000 | 22.18 | 44.4K | 79,259 | — | ↗ |
| 2021-07-15 | Neill Andrew R | Officer | S-Sale | D | Common Stock | 2,000 | 22.13 | 44.3K | 53,963 | — | ↗ |
| 2021-07-15 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 34 | 22.74 | 773.16 | 2,966,709 | — | ↗ |
| 2021-07-14 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 12,049 | 23.14 | 278.8K | 2,966,743 | — | ↗ |
| 2021-07-13 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 4,356 | 25.12 | 109.4K | 2,978,792 | — | ↗ |
| 2021-07-12 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 2,829 | 26.15 | 74.0K | 2,983,148 | — | ↗ |
| 2021-07-09 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 3,276 | 26.54 | 86.9K | 2,985,977 | — | ↗ |
| 2021-07-08 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 3,586 | 26.24 | 94.1K | 2,989,253 | — | ↗ |
| 2021-07-07 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 4,271 | 26.17 | 111.8K | 2,992,839 | — | ↗ |
| 2021-07-06 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 2,621 | 27.32 | 71.6K | 2,997,110 | — | ↗ |
| 2021-07-02 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 2,514 | 28.53 | 71.7K | 2,999,731 | — | ↗ |
| 2021-07-01 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,669 | 28.81 | 221.0K | 3,002,245 | — | ↗ |
| 2021-06-30 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 17,891 | 28.65 | 512.6K | 3,009,914 | — | ↗ |
| 2021-06-29 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 6,921 | 26.89 | 186.1K | 3,027,805 | — | ↗ |
| 2021-06-28 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 8,091 | 28.00 | 226.6K | 3,034,726 | — | ↗ |
| 2021-06-25 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 16,210 | 28.20 | 457.1K | 3,042,817 | — | ↗ |
| 2021-06-24 | Hornblower Josiah | Director | M-Exempt | D | Stock Option (Right to Buy) | 188,375 | 4.67 | 879.7K | 0 | — | ↗ |
| 2021-06-23 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,832 | 28.29 | 165.0K | 3,066,643 | — | ↗ |
| 2021-06-21 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 9,245 | 29.82 | 275.7K | 3,072,475 | — | ↗ |
| 2021-06-20 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,382 | 29.96 | 221.2K | 3,081,720 | — | ↗ |
| 2021-06-19 | Redmile Group, LLC | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-19 | Lee Michael Stewart | Director | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-19 | Hornblower Josiah | Director | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-19 | Golumbeski George | Director | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-19 | Gibson Neil W | Director | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-19 | Brous Tyler | Director | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-19 | Boudreau Helen M | Director | A-Award | A | Stock Option (Right to Buy) | 3,434 | 29.34 | 100.8K | 3,434 | — | ↗ |
| 2021-06-18 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 3,000 | 30.00 | 90.0K | 81,259 | — | ↗ |
| 2021-06-18 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 9,840 | 29.00 | 285.3K | 3,089,102 | — | ↗ |
| 2021-06-17 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 8,469 | 28.76 | 243.6K | 3,098,942 | — | ↗ |
| 2021-06-16 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 8,691 | 27.80 | 241.6K | 3,107,411 | — | ↗ |
| 2021-06-15 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 4,000 | 27.55 | 110.2K | 84,259 | — | ↗ |
| 2021-06-15 | Neill Andrew R | Officer | S-Sale | D | Common Stock | 2,000 | 27.53 | 55.1K | 55,963 | — | ↗ |
| 2021-06-15 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,293 | 27.47 | 200.3K | 3,116,102 | — | ↗ |
| 2021-06-14 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,356 | 29.05 | 155.6K | 3,123,395 | — | ↗ |
| 2021-06-11 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 4,392 | 29.41 | 129.2K | 3,128,751 | — | ↗ |
| 2021-06-10 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,316 | 28.67 | 152.4K | 3,133,143 | — | ↗ |
| 2021-06-09 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,601 | 29.21 | 222.0K | 3,138,459 | — | ↗ |
| 2021-06-08 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 3,000 | 30.00 | 90.0K | 88,259 | — | ↗ |
| 2021-06-08 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 9,229 | 29.72 | 274.3K | 3,146,060 | — | ↗ |
| 2021-06-07 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 10,736 | 29.45 | 316.2K | 3,155,289 | — | ↗ |
| 2021-06-04 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,047 | 28.57 | 201.4K | 3,166,025 | — | ↗ |
| 2021-06-03 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,494 | 27.30 | 150.0K | 3,173,072 | — | ↗ |
| 2021-06-02 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 6,399 | 27.64 | 176.9K | 3,178,566 | — | ↗ |
| 2021-06-01 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,931 | 27.41 | 162.6K | 3,184,965 | — | ↗ |
| 2021-06-01 | Brous Tyler | Director | J-Other | D | Common Stock | 87,132 | 0.00 | — | 0 | — | ↗ |
| 2021-05-28 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 8,747 | 27.18 | 237.7K | 3,190,896 | — | ↗ |
| 2021-05-27 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 4,923 | 26.37 | 129.8K | 3,199,643 | — | ↗ |
| 2021-05-26 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,320 | 24.74 | 131.6K | 3,204,566 | — | ↗ |
| 2021-05-25 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,159 | 24.87 | 128.3K | 3,209,886 | — | ↗ |
| 2021-05-24 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,456 | 25.23 | 137.6K | 3,215,045 | — | ↗ |
| 2021-05-21 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 4,330 | 25.07 | 108.5K | 2,610,750 | — | ↗ |
| 2021-05-21 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,977 | 25.58 | 152.9K | 3,220,501 | — | ↗ |
| 2021-05-20 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 7,378 | 26.19 | 193.2K | 2,621,295 | — | ↗ |
| 2021-05-20 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,532 | 26.20 | 197.3K | 3,226,478 | — | ↗ |
| 2021-05-19 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 7,794 | 24.63 | 192.0K | 2,628,673 | — | ↗ |
| 2021-05-19 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 7,747 | 24.65 | 191.0K | 3,234,010 | — | ↗ |
| 2021-05-18 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 4,998 | 26.05 | 130.2K | 2,636,467 | — | ↗ |
| 2021-05-18 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 5,107 | 26.03 | 132.9K | 3,241,757 | — | ↗ |
| 2021-05-17 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 4,000 | 26.25 | 105.0K | 91,259 | — | ↗ |
| 2021-05-17 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 6,139 | 26.28 | 161.3K | 2,641,465 | — | ↗ |
| 2021-05-17 | Neill Andrew R | Officer | S-Sale | D | Common Stock | 2,000 | 26.27 | 52.5K | 57,963 | — | ↗ |
| 2021-05-17 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 6,336 | 26.30 | 166.7K | 3,246,864 | — | ↗ |
| 2021-05-14 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 11,077 | 26.25 | 290.8K | 2,647,604 | — | ↗ |
| 2021-05-14 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 11,095 | 26.24 | 291.1K | 3,253,200 | — | ↗ |
| 2021-05-13 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 9,856 | 25.91 | 255.4K | 2,658,681 | — | ↗ |
| 2021-05-13 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 10,090 | 25.88 | 261.1K | 3,264,295 | — | ↗ |
| 2021-05-13 | Brous Tyler | Director | J-Other | A | Common Stock | 6,593 | 0.00 | — | 181,406 | — | ↗ |
| 2021-05-12 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 14,242 | 27.29 | 388.6K | 2,668,537 | — | ↗ |
| 2021-05-12 | Neill Andrew R | Officer | M-Exempt | D | Stock Option (Right to Buy) | 8,860 | 0.01 | 88.60 | 2,203 | — | ↗ |
| 2021-05-12 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 14,057 | 27.27 | 383.3K | 3,274,385 | — | ↗ |
| 2021-05-11 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 14,783 | 28.03 | 414.3K | 2,682,779 | — | ↗ |
| 2021-05-11 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 15,040 | 28.04 | 421.7K | 3,288,442 | — | ↗ |
| 2021-05-10 | Schreiber Taylor | Director / Officer | S-Sale | D | Common Stock | 8,188 | 26.98 | 220.9K | 2,697,562 | — | ↗ |
| 2021-05-10 | Hornblower Josiah | Director | S-Sale | D | Common Stock | 8,227 | 26.94 | 221.6K | 3,303,482 | — | ↗ |
| 2021-04-28 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 5,000 | 35.00 | 175.0K | 95,259 | — | ↗ |
| 2021-04-28 | Neill Andrew R | Officer | S-Sale | D | Common Stock | 20,000 | 35.00 | 700.0K | 51,103 | — | ↗ |
| 2021-04-15 | Thomson Erin Ator | Officer | S-Sale | D | Common Stock | 7,000 | 30.77 | 215.4K | 100,259 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-11.7K
Shares Outstanding
47.90M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 565.6K | — | — | 656.5K | 296.9K | 13.7K | 1.53M | 42.83% | ↗ |
| 2 | 2025 | Arunthathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 503.0K | — | — | 197.7K | 211.3K | 20.7K | 932.6K | 21.20% | ↗ |
| 3 | 2025 | Andrew R. Neill Chief Financial Officer | 467.2K | — | — | 205.2K | 196.2K | 14.8K | 883.4K | 23.23% | ↗ |
| 4 | 2024 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 560.0K | — | — | 2.47M | 168.0K | 14.6K | 3.22M | 76.91% | ↗ |
| 5 | 2024 | Andrew R. Neill Chief Financial Officer | 458.0K | — | 570.1K | 900.6K | 109.9K | 14.0K | 2.05M | 71.65% | ↗ |
| 6 | 2024 | Arunthathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 498.0K | — | 468.9K | 740.8K | 119.5K | 22.1K | 1.85M | 65.41% | ↗ |
| 7 | 2023 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 525.0K | — | — | 241.5K | 262.5K | 5.4K | 1.03M | 23.35% | ↗ |
| 8 | 2023 | Arunthathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 479.0K | — | 135.2K | 182.9K | 191.6K | 24.6K | 1.01M | 31.39% | ↗ |
| 9 | 2023 | Andrew R. Neill Chief Financial Officer | 430.0K | — | 124.7K | 183.1K | 172.0K | 2.0K | 911.8K | 33.76% | ↗ |
| 10 | 2023 | Andrew R. Neill Chief Financial Officer | 430.0K | — | 124.7K | 183.1K | 172.0K | 2.0K | 911.8K | 33.76% | ↗ |
| 11 | 2022 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 525.0K | — | — | 680.6K | 249.4K | 10.2K | 1.47M | 46.45% | ↗ |
| 12 | 2022 | Arunthathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 479.0K | — | 258.1K | 362.6K | 182.0K | 18.5K | 1.30M | 47.74% | ↗ |
| 13 | 2022 | Arundathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 479.0K | — | 258.1K | 362.6K | 182.0K | 17.7K | 1.30M | 47.77% | ↗ |
| 14 | 2022 | Abhinav Shukla, Ph.D. Chief Technical Officer | 406.0K | — | 165.9K | 466.0K | 154.3K | 7.1K | 1.20M | 52.69% | ↗ |
| 15 | 2021 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 525.0K | — | — | — | 199.5K | 20.0K | 744.5K | 0.00% | ↗ |
| 16 | 2021 | Arundathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 465.0K | — | — | — | 150.3K | 23.2K | 638.4K | 0.00% | ↗ |
| 17 | 2021 | Casi DeYoung Chief Business Officer | 380.0K | — | — | — | 122.8K | 20.7K | 523.5K | 0.00% | ↗ |
| 18 | 2020 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 394.5K | 116.4K | — | — | — | 15.2K | 2.10M | 0.00% | ↗ |
| 19 | 2020 | Taylor Schreiber, M.D., Ph.D. Chief Executive Officer | 394.5K | — | — | 1.57M | 116.4K | 15.2K | 2.10M | 74.89% | ↗ |
| 20 | 2020 | Arundathy Nirmalini (Lini) Pandite, MBChB Chief Medical Officer | 417.5K | 147.7K | — | — | — | 17.8K | 1.83M | 0.00% | ↗ |
| 21 | 2020 | Arundathy Nirmalini (Lini) Pandite, M.B.Ch.B. Chief Medical Officer | 417.5K | — | — | 1.25M | 147.7K | 17.8K | 1.83M | 68.17% | ↗ |
| 22 | 2020 | Josiah Hornblower Chairman Former CEO and Executive Chairman | 325.0K | 94.6K | — | — | — | 854.00 | 1.46M | 0.00% | ↗ |
| 23 | 2020 | Casi DeYoung Chief Business Officer | 340.0K | — | — | 773.2K | 98.9K | 1.7K | 1.21M | 63.70% | ↗ |
| 24 | 2020 | Casi DeYoung Chief Business Officer | 340.0K | 98.9K | — | — | — | 1.7K | 1.21M | 0.00% | ↗ |
| 25 | 2019 | Arundathy Nirmalini (Lini) Pandite, MBChB Chief Medical Officer | 405.0K | 120.5K | — | — | — | 11.9K | 537.4K | 0.00% | ↗ |
| 26 | 2019 | Josiah Hornblower Chairman Former CEO and Executive Chairman | 325.0K | 58.5K | — | — | — | 868.00 | 384.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Taylor H. Schreiber | Co-Founder, Chief Executive Officer & Director | 876.2K | — |
| Arundathy Nirmalini Pandite | Chief Medical Officer | 734.9K | — |
| Andrew R. Neill | Chief Financial Officer | 678.2K | male |
| Abhinav A. Shukla | Chief Technical Officer | 567.4K | — |
| Casi DeYoung | Chief Business Officer | 523.5K | female |
| Thomas Lampkin | Senior Vice President of Regulatory Affairs | — | — |
| Brad Huckabee | Vice President of Accounting & SEC reporting | — | male |
| Kelli Collin | Senior Vice President of Quality | — | female |
| Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer | — | male |
| Suresh de Silva | Chief Scientific Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for STTK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
